Status:
UNKNOWN
The Treatment of Bronchopulmonary Dysplasia by Instillation PS and Mononuclaer Cells in Preterms
Lead Sponsor:
yangjie
Conditions:
Neonates Premature
Ventilator Support
Eligibility:
All Genders
28-36 years
Phase:
PHASE1
Brief Summary
Bronchopulmonary dysplasia mainly occurs in premature infants, which is the main cause of premature infant death.If children with BPD can survive, they are also prone to complications of long-term res...
Detailed Description
This is a Phase 1 clinical trial that constitues one time points cohor and three group,each group with 80 participants,which receive intratracheal PS and mononuclaer cells,receive intratracheal PS,rec...
Eligibility Criteria
Inclusion
- twenty-eight weeks to thirty-seven weeks
Exclusion
- Pretem infants with major congenital malformations,chromosomal anomalies,inborn errors of metabolism and clinical or laboratory evidence of a congenital infection
Key Trial Info
Start Date :
February 24 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 20 2020
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT03855202
Start Date
February 24 2019
End Date
August 20 2020
Last Update
February 26 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.